Key result
Diabetes linked to ~2.4-fold higher in-hospital mortality after aortic valve replacement.
Why the study?
Diabetes mellitus is implicated in aortic valve stenosis development and adverse outcomes after aortic valve replacement, warranting a comprehensive review.
Does diabetes mellitus increase the risk of early mortality, late mortality, and stroke in patients with aortic valve stenosis undergoing aortic valve replacement?
Meta-Analysis (n=760,287)
Yes
Does diabetes mellitus increase the risk of early mortality, late mortality, and stroke in patients with aortic valve stenosis undergoing aortic valve replacement?
Answers are grounded in this paper and cite their sources.
This large-scale meta-analysis demonstrates that diabetes mellitus is present in roughly one-third of patients with aortic valve stenosis and significantly increases the risk of in-hospital mortality, 30-day mortality, and stroke following surgical or transcatheter aortic valve replacement, though it does not significantly impact late mortality (≥1 year).
BACKGROUND: Given the importance of diabetes mellitus (DM) and its role in the development of aortic valve stenosis (AVS), as well as its association with adverse outcomes after aortic valve replacement (AVR), the present meta analysis aimed to provide a comprehensive review of previous studies in this field. METHODS: To achieve this objective, a thorough literature search was conducted in PUBMED/MEDLINE, ScienceDirect, CINAHL, EMBASE/SCOPUS, PsycINFO, ClinicalKey, the Cochrane Central Register of Controlled Trials (CENTRAL), ProQuest, Web of Science, and Persian databases such as SID and Magiran. The number of patients, gender ratio, mean age, prevalence of T2DM, AVS, and treatment outcomes after TAVI, TAVR, and SAVR (stroke, early and late mortality) were recorded. RESULTS: This metaanalysis comprised 22 studies involving a total of 760,287 patients with AVS. The pooled prevalence of DM was approximately 31% (95% CI: 26-36%). DM was associated with a significantly higher risk of early mortality, including both inhospital mortality (OR: 2.399) and 30day mortality (OR: 1.45), compared with nonDM patients (p<0.05). However, the increase in late mortality (one year or longer) among DM patients was not statistically significant. Additionally, DM patients showed a significantly elevated risk of stroke compared with nonDM patients (OR: 1.15; 95% CI: 1.03-1.28; p=0.009). CONCLUSION: Overall, DM appears to play a significant role in the development of AVS and is associated with adverse outcomes including mortality and stroke after AVR.
No takes yet. Share an insight, caveat, or question.
Hosseini et al. (2026) conducted a meta-analysis in Aortic valve stenosis undergoing surgical or transcatheter aortic valve replacement (n=760,287). Diabetes mellitus vs. No diabetes mellitus was evaluated on In-hospital mortality after aortic valve replacement (OR 2.399, 95% CI 2.23-2.59, p=<0.001). Diabetes mellitus was associated with higher in-hospital, 30-day mortality, and stroke after aortic valve replacement.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: